---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-282873"
form_type: "8-K"
ticker: "FULC"
cik: "0001680581"
company_name: "Fulcrum Therapeutics, Inc."
filed_at: "2026-06-25T20:32:25+00:00"
generated_at: "2026-06-25T20:33:12.392571+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Fulcrum stockholders elect three Class I directors, approve advisory compensation, ratify auditor

## Summary
- Sonja Banks, Alan Ezekowitz, Colin Hill elected as Class I directors for three-year terms ending 2029.
- Advisory vote on named executive officer compensation approved with 50.7M for, 3.0M against.
- Ratification of Ernst & Young as FY2026 auditor approved with 58.8M for, 36K against.

## SEC filing metadata
- accession: 0001193125-26-282873
- form_type: 8-K
- ticker: FULC
- cik: 0001680581
- company_name: Fulcrum Therapeutics, Inc.
- filed_at: 2026-06-25T20:32:25+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680581/000119312526282873/0001193125-26-282873-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680581/000119312526282873/d159102d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-282873
- JSON: https://secwatch.observer/filing/0001193125-26-282873.json
- Plain text: https://secwatch.observer/filing/0001193125-26-282873.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.